Senate's Bipartisan Rx Pricing Probe Seeks Documents Regarding FDA Regs
This article was originally published in The Pink Sheet Daily
Executive Summary
Probe launched by the Senate Aging panel asks four manufacturers – Valeant, Turing, Retrophin and Rodelis – for documents pertaining to pricing their products, but also wants to know how they may have analyzed FDA regs to help them avoid competition.